Google
Apple
English (UK)
English (India)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
FORTIS HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 382.05 INR | -0.91% | -0.46% | +33.54% | |
| Nov. 27 | Fortis Healthcare to Sell Fortis Malar Hospital for INR1.3 Billion | MT |
| Nov. 27 | IHH Healthcare Associate Divesting Indian Hospital for INR1.3 Billion | MT |
| Sales 2024 * | 70.06B 840M | Sales 2025 * | 80.26B 962M | Capitalization | 288B 3.46B |
|---|---|---|---|---|---|
| Net income 2024 * | 6.29B 75.37M | Net income 2025 * | 8.3B 99.48M | EV / Sales 2024 * | 4,16x |
| Net Debt 2024 * | 2.84B 34.1M | Net cash position 2025 * | 65M 779K | EV / Sales 2025 * | 3,59x |
| P/E ratio 2024 * | 45,5x | P/E ratio 2025 * | 34,4x | Employees | 13,010 |
| Yield 2024 * | 0,27% | Yield 2025 * | 0,36% | Free-Float | 95.54% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
| 1 day | -0.91% | ||
| 1 week | -0.46% | ||
| Current month | -1.02% | ||
| 1 month | +12.29% | ||
| 3 months | +12.60% | ||
| 6 months | +36.06% | ||
| Current year | +33.54% |
1 week
377.20
390.00
1 month
341.05390.00
Current year
245.50390.00
1 year
245.50390.00
3 years
141.75390.00
5 years
111.30390.00
10 years
93.10390.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 2019 | |
Daljit Singh
PSD | President | 70 | 2002 |
| Director of Finance/CFO | - | 2019 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 2018 | |
| Chief Executive Officer | 61 | 2019 | |
Ravi Rajagopal
CHM | Chairman | 68 | 2018 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.65% | 443 M€ | -.--% | - | |
| 0.29% | 40 M€ | +3.16% | - | |
| 0.25% | 6 M€ | +6.07% | - | |
| 0.18% | 296 M€ | +17.50% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-08 | 382.05 | -0.91% | 1,682,641 |
| 23-12-07 | 385.55 | -0.10% | 578,385 |
| 23-12-06 | 385.95 | -0.52% | 1,832,423 |
| 23-12-05 | 387.95 | +0.15% | 1,443,081 |
| 23-12-04 | 387.35 | +0.92% | 2,477,746 |
Delayed Quote NSE India Stock Exchange, December 08, 2023 at 06:43 am EST
More quotes
Fortis Healthcare Limited is an India-based integrated healthcare delivery service provider. The Company is primarily engaged in the business of healthcare services. The Company operates through healthcare services segment. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, pulmonology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. It manages and operates a network of multi-specialty hospitals and diagnostics centers. The healthcare verticals of the Company primarily consist of hospitals, diagnostics, and day care specialty facilities. It has approximately 27 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. It operates in India, United Arab Emirates and Sri Lanka. Its subsidiaries include Escorts Heart Institute and Research Centre Limited, Fortis Health staff Limited, and Fortis Asia Healthcare Pte. Ltd, among others.
Calendar
2024-02-14
- Q3 2024 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
382.05INR
Average target price
408.57INR
Spread / Average Target
+6.94%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +33.54% | 3 457 M $ | |
| -31.72% | 21 251 M $ | |
| +8.69% | 17 277 M $ | |
| -11.21% | 11 526 M $ | |
| -5.79% | 11 027 M $ | |
| +24.07% | 9 572 M $ | |
| -24.99% | 7 291 M $ | |
| +8.34% | 6 496 M $ | |
| +10.05% | 6 132 M $ | |
| +12.78% | 5 975 M $ |
